In vitro Bioequivalence for suspension ophthalmic [Regulatives / Guidelines]

posted by Weidson – Brazil, 2018-04-09 22:40 (2503 d 13:53 ago) – Posting: # 18658
Views: 2,045

Dear All,

Has anyone in this group ever performed an in vitro bioequivalence study with an ophthalmic suspension that was guided by the Guidance on Dexamethasone / tobramycin (reviewed June 2012, June 2013 and June 2016)? If yes, what is the acceptance criterion for bioequivalence? In the draft nothing is mentioned for the range of acceptance of the mortality rate of the microorganisms.

https://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm308032.pdf

Thanks vary much.

Complete thread:

UA Flag
Activity
 Admin contact
23,380 posts in 4,914 threads, 1,665 registered users;
71 visitors (0 registered, 71 guests [including 8 identified bots]).
Forum time: 11:34 CET (Europe/Vienna)

When people learn no tools of judgment
and merely follow their hopes,
the seeds of political manipulation are sown.    Stephen Jay Gould

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5